Adherence therapy following an acute episode of schizophrenia: A multi-centre randomised controlled trial

Schizophrenia Research

Volumn 146, Issue 1-3, 2013, Pages 59-63

  Schulz, Michael ^a,b   Gray, Richard ^c   Spiekermann, Alexa ^b   Abderhalden, Christoph ^d   Behrens, Johann ^e   Driessen, Martin ^b  

^a BIELEFELD UNIVERSITY OF APPLIED SCIENCES   (Germany)

^b Department of Psychiatry and Psychotherapy Bethel ^*

^c UNIVERSITY OF THE WEST OF ENGLAND   (United Kingdom)

^d UNIVERSITY OF BERN   (Switzerland)

^e MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Adherence; Antipsychotic; Compliance; Schizophrenia

Indexed keywords

NEUROLEPTIC AGENT;

ADHERENCE THERAPY; ADULT; ARTICLE; BEHAVIOR THERAPY; CONTROLLED STUDY; FEMALE; GERMANY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OCCUPATIONAL THERAPY; PARALLEL DESIGN; PATIENT ATTITUDE; PATIENT COMPLIANCE; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; PSYCHOEDUCATION; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIAL; SCHIZOPHRENIA; SINGLE BLIND PROCEDURE; SWITZERLAND; THERAPY EFFECT; TREATMENT OUTCOME;

ADULT; ANTIPSYCHOTIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; RETROSPECTIVE STUDIES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; TREATMENT OUTCOME;

EID: 84875951273     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2013.01.028     Document Type: Article

References (24)

1. Alhalaiqa F., Deane K.H.O., Nawafleh A.H., et al. Adherence therapy for medication non-compliant patients with hypertension: a randomized controlled trial. J. Hum. Hypertens. 2012, 26:117-126.
2. American Psychiatric Association Diagnostic and statistical manual of mental disorders. Text Revision (DSM-IV-TR) 2000, American Psychiatric Association, Washington, D.C. 4th ed.
3. Anderson K., Ford S., Robson D., et al. An exploratory, randomized controlled trial of adherence therapy for people with schizophrenia. Int. J. Ment. Health Nurs. 2010, 19:340-349.
4. Armitage P., Berry G., Matthews N.S. Statistical Methods in Medical Research 2000, Blackwell Science Ltd., Oxford, U.K. 4th ed.
5. Caplan C. Principles of Preventive Psychiatry 1964, Basic Books, Inc., New York.
6. David A. Treatment adherence in psychoses. Br. J. Psychiatry 2010, 197:431-432.
7. Endicott J., Spitzer R.L., Fleiss J.L., Cohen J. The global assessment scale: a procedure for measuring overall severity of psychiatric disturbance. Arch. Gen. Psychiatry 1976, 33:766-771.
8. Gerhold, M., Huss, M., Luecke, M. 1999. "PANSS", Germany.
9. Gray R., Wykes T., Edmonds M., et al. Effect of a medication management training package for nurses on clinical outcomes for patients with schizophrenia: cluster randomised controlled trial. Br. J. Psychiatry 2004, 185:157-162.
10. Gray R., Leese M., Bindman J., et al. Adherence therapy for people with schizophrenia. European multicentre randomised controlled trial. Br. J. Psychiatry 2006, 189:508-514.
11. Hogan T.P., Awad A.G., Eastwood R. A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validity. Psychol. Med. 1983, 13:177-183.
12. Horne R., Weinmann J., Hankins M. The Beliefs about Medicines Questionnaire: The development and evaluation of a new method for assessing the cognitive representation of medication. Psychol. Health 1999, 14:1-24.
13. Kay S.R., Fiszbein A., et al. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr. Bull. 1987, 13:261-276.
14. Kemp R., Kirov G., Everitt B., Hayward P., David A. Randomized controlled trial of compliance therapy. 18-month follow-up. Br. J. Psychiatry 1998, 172:413-419.
15. Maneesakorn S., Robson D., Gournay K., Gray R. An RCT of adherence therapy for people with schizophrenia in Chiang Mai, Thailand. J. Clin. Nurs. 2007, 16:1302-1312.
16. Mickey R.M., Dunn O.J., Clark V.A. Applied Statistics: Analysis of Variance and Regression 2004, John Wily, New York. 3rd ed.
17. Nunes V., Neilson J., O'Flynn N., et al. Clinical Guidelines and Evidence Review for Medicines Adherence: Involving Patients in Decisions about Prescribed Medicines and Supporting Adherence 2009, National Collaborating Centre for Primary Care and Royal College of General Practitioners, London.
18. O'Donell C., Donohoe G., Sharkey L., et al. Compliance therapy: a randomized controlled trial in schizophrenia. BMJ 2003, 327:834.
19. Robinson D., Woerner M.G., Alvir M., et al. Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder. Arch. Gen. Psychiatry 1999, 56:241-247.
20. Staring A.Van, der Gaag M., Koopmans J.P., et al. Treatment adherence therapy in people with psychotic disorder: randomized controlled trial. Br. J. Psychiatry 2010, 197:448-455.
21. Thompson K., Kulkarni J., Sergejew A.A. Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses. Schizophr. Res. 2000, 5:241-247.
22. Velligan D.I., Wang M., Diamond P., et al. Relationships among subjective and objective measures of adherence to oral antipsychotic medications. Psychol. Serv. 2007, 58:1187-1192.
23. Velligan D., Weiden P., Sajatovic M., et al. Expert consensus panel on adherence problems in serious and persistent mental illness. The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness. J. Clin. Psychiatry 2009, 70(Supplement 4):1-46.
24. World Health Organization Adherence to long-term therapies evidence for action. Non-communicable diseases and mental health. Adherence to Long-term Therapies Project 2003, World Health Organization, Geneva.